Drug Type Small molecule drug |
Synonyms Acetylcysteine/oxpentifylline, Oxpentifylline/acetylcysteine, Pentoxifylline/acetylcysteine + [1] |
Action inhibitors |
Mechanism Free radicals inhibitors, Phosphoric diester hydrolases inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H18N4O3 |
InChIKeyBYPFEZZEUUWMEJ-UHFFFAOYSA-N |
CAS Registry6493-05-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 1 | India | - | |
Idiopathic Pulmonary Fibrosis | Phase 1 | - | - | |
Idiopathic Pulmonary Fibrosis | Phase 1 | - | - |